Large Cap Biopharma Stalled With Move to Small Caps and Reflation Trade

Defensive large-cap biopharma stocks stalled as traders moved out on the risk curve seeking faster gains.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.